Skip to main content

Table 1 Clinical characteristics of patients with bladder cancer who underwent radical cystectomy with TIVA-TCI or BAL anesthesia

From: Immunomodulatory effects of total intravenous and balanced inhalation anesthesia in patients with bladder cancer undergoing elective radical Cystectomy: preliminary results

  All cancer patients (n. 28) TIVA-TCI (n. 14) BAL (n. 14) P TIVA-TCI vs. BAL
Age (yrs) 62.04 ± 8.63 63.2 ± 6.8 61.2 ± 10.8 0.57
Sex , n (%)     
 males 23 (82.1%) 12 (85.7%) 11 (78.6%) 0.62
 females 5 (17.9%) 2 (14.3%) 3 (21.4%)  
Histological type of cancer     
 High grade urothelial carcinoma 28 (100%) 14 (100%) 14 (100%) 1.00
pT, n (%)     
 1-2 11 (39.3%) 6 (42.9%) 5 (35.7%) 0.70
 3 17 (60.7%) 8 (57.1%) 9 (64.3%)  
pN, n (%)     
 0 22 (78.6%) 12 (85.7%) 10 (71.4%) 0.34
 1 2 (7.1%) 0 2 (14.3%)  
 2 4 (14.3%) 2 (14.3%) 2 (14.3%)  
ASA, n (%):     
 I-II 18 (64.3%) 9 (64.3%) 9 (64.3%) 1.00
 III 10 (35.7%) 5 (35.7%) 5 (35.7%)  
Weight (BMI ) 25.8 ± 4.2 27.1 ± 5.9 25.1 ± 3.0 0.55
Time of surgery (h) 3.12 ± 0.59 3.08 ± 0.58 3.17 ± 0.56 0.27
Time of anaesthesia (h) 3.27 ± 0.48 3.18 ± 0.45 3.35 ± 0.51 0.42
Time of hospitalization (days) 13.29 ± 1.00 13.58 ± 0.99 13.00 ± 0.95 0.16
Metastasis after surgery, n (%) 4 (14.3%) 1 (7.1%) 3 (21.4%) 0.28
Death from cancer, n (%) 5 (17.9%) 1 (7.1%) 4 (28.6%) 0.14
Death from any cause, n (%) 7 (25.0%) 2 (14.3%) 5 (35.7%) 0.19
  1. Values are expressed in absolute values or mean ± SD.